Related Experiment Video
Updated: Jul 15, 2025
07:44
Localization of the Locus Coeruleus in the Mouse Brain
Published on: March 7, 2019
17.9K
Interactive effects of locus coeruleus structure and catecholamine synthesis capacity on cognitive function.
Hsiang-Yu Chen1, Jourdan H Parent1, Claire J Ciampa1
1Department of Psychology, Brandeis University, Waltham, MA, United States.
Frontiers in Aging Neuroscience
|September 25, 2023
Summary
Locus coeruleus (LC) MRI and PET scans show structure and catecholamine synthesis are linked to cognitive functions like executive function. Combining these neuroimaging methods may improve detecting brain-behavior links.
Area of Science:
- Neuroscience
- Cognitive Science
- Neuroimaging
Background:
- The locus coeruleus (LC) is crucial for cognitive functions like attention and executive function.
- Advancements in MRI allow for LC structure quantification, fueling research into its role in psychopathology and neurodegenerative diseases.
- The relationship between LC structure, catecholamine function, and cognitive performance remains unclear.
Purpose of the Study:
- To investigate the association between locus coeruleus (LC) structure and catecholamine synthesis capacity.
- To determine how LC structure and neurochemical function relate to cognitive performance.
Main Methods:
- Partial least squares correlation (PLSC) analysis was used.
- 19 participants' LC structural MRI and [18F]Fluoro-m-tyrosine ([18F]FMT) PET measures were analyzed.
- Neuropsychological performance was assessed.
Main Results:
- No direct association was found between LC MRI and LC-[18F]FMT measures.
- LC neuroimaging measures were significantly associated with neuropsychological performance, particularly in rostral and middle LC portions.
- Executive function and processing speed associations involved contributions from LC structure and its interaction with catecholamine synthesis capacity.
Conclusions:
- LC MRI and PET measures may offer unique, complementary information.
- Conjoint use of LC MRI and PET may enhance sensitivity to brain-behavior associations, especially in smaller sample sizes.
Keywords:
catecholamine synthesis capacitylocus coeruleuspartial least squares correlationpositron emission tomographystructural magnetic resonance imagingMore Related Videos
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
147
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
147
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
01:25Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
01:27Adrenergic Neurons: Neurotransmission
3.9K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.9K
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
224
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
224